The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030

B Vogel, M Acevedo, Y Appelman, CNB Merz… - The Lancet, 2021 - thelancet.com
Cardiovascular disease is the leading cause of death in women. Decades of grassroots
campaigns have helped to raise awareness about the impact of cardiovascular disease in …

Transcatheter mitral valve replacement: insights from early clinical experience and future challenges

A Regueiro, JF Granada, F Dagenais… - Journal of the American …, 2017 - jacc.org
Transcatheter mitral valve repair, particularly edge-to-edge leaflet repair, is a well-
established alternative for patients with severe primary mitral regurgitation (MR) considered …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

H Baumgartner, V Falk, JJ Bax… - Polish Heart …, 2018 - journals.viamedica.pl
Recenzenci dokumentu: Marco Roffi, koordynator recenzji ze strony CPG (Szwajcaria),
Ottavio Alfieri1, koordynator recenzji ze strony EACTS (Włochy), Stefan Agewall (Norwegia) …

[PDF][PDF] 2017 ESC/EACTS Guidelines for the management of valvular heart disease

V Falk, H Baumgartner, JJ Bax… - European Journal of …, 2017 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Guidelines for the evaluation of valvular regurgitation after percutaneous valve repair or replacement: a report from the American Society of Echocardiography …

WA Zoghbi, FM Asch, C Bruce, LD Gillam… - Journal of the American …, 2019 - Elsevier
Valvular disease remains a major cause of cardiovascular morbidity and mortality
worldwide. 1 Over the past decade, catheter-based interventions in valvular disease have …

1-year outcomes of transcatheter mitral valve replacement in patients with severe mitral annular calcification

M Guerrero, M Urena, D Himbert, DD Wang… - Journal of the American …, 2018 - jacc.org
Background: The risk of surgical mitral valve replacement in patients with severe mitral
annular calcification (MAC) is high. Several patients worldwide with severe MAC have been …

Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement

SH Yoon, S Bleiziffer, A Latib, L Eschenbach… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: The aim of this study was to evaluate the predictors of left ventricular outflow tract
(LVOT) obstruction after transcatheter mitral valve replacement (TMVR). Background: LVOT …

The BASILICA trial: prospective multicenter investigation of intentional leaflet laceration to prevent TAVR coronary obstruction

JM Khan, AB Greenbaum, VC Babaliaros… - JACC: Cardiovascular …, 2019 - jacc.org
Abstract Objectives: The BASILICA (Bioprosthetic or native Aortic Scallop Intentional
Laceration to prevent Iatrogenic Coronary Artery obstruction during TAVR) investigational …

Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native …

M Guerrero, S Vemulapalli, Q **ang… - Circulation …, 2020 - Am Heart Assoc
Background: Transcatheter mitral valve replacement using aortic transcatheter heart valves
has recently become an alternative for patients with degenerated mitral bioprostheses, failed …

Transcatheter mitral valve replacement for degenerated bioprosthetic valves and failed annuloplasty rings

SH Yoon, BK Whisenant, S Bleiziffer, V Delgado… - Journal of the American …, 2017 - jacc.org
Background: Limited data exist regarding transcatheter mitral valve replacement (TMVR) for
patients with failed mitral valve replacement and repair. Objectives: This study sought to …